Chronic Idiopathic Constipation Market Revenue, Region & Country Share, Trends, Growth Analysis Till 2027

 

Chronic Idiopathic Constipation Market

The chronic idiopathic constipation market trends are expected to rise at a good rate and attain excellent market revenue after the outbreak of the pandemic on the market during the ongoing forecast period of 2021-2028. The chronic idiopathic constipation market is likely to grow at a global CAGR that accounts for 7% and is likely to be attained by the end of the forecast period in 2028.

The market in Asia Pacific is expected to grow rapidly in the coming years. By studying and analyzing the market, it shows that this region has a good growth potential due to increasing unhealthy eating habits and unhygienic conditions. The other major chronic disease found in this region is the gastric cancer.

Segmentation

The global chronic idiopathic constipation market is segmented on the basis of diagnosis, treatment, and end-user. On the basis of diagnosis, the market is segmented into blood tests, sigmoidoscopy, colonoscopy, balloon expulsion tests, anorectal manometry, colonic transit study, defecography, and others. On the basis of chronic idiopathic constipation treatment, the market is segmented into drug and surgery. Drugs are further segmented into acid neutralizers, laxatives and antidiarrheal, antiemetics, antiulcer, lubiprostone (amitiza) and linaclotide (linzess), misoprostol (Cytotec), colchicine/probenecid (Col-Probenecid) and Onabotulinumtoxin A (also called botulinum toxin type A or Botox), and others. On the basis of end-user, the market is segmented into hospitals, gastroenterology clinics, diagnostic centers, and others.

Regional Analysis

The Americas dominates the global chronic idiopathic constipation market owing to the increasing prevalence of chronic constipation and the presence of a well-developed healthcare sector within the region. Moreover, the increasing healthcare expenditure and the presence of key players within regional boundaries provide a favorable background for the market growth.

Europe is the second largest in the global chronic idiopathic constipation market. Factors such as the increasing availability of funds for research and a huge patient population followed by a well-developed healthcare sector drive the market within the region.

Asia Pacific is estimated to be the fastest growing market for chronic idiopathic constipation. This can be attributed to the presence of developing economies such as India and China and a huge patient population. Moreover, the increasing healthcare expenditure and a rapidly developing healthcare sector boost the market growth within the region.

On the other hand, the Middle East and Africa has the least share in the global chronic idiopathic constipation market due to the low per capita healthcare expenditure and stringent government policies, especially within the African region. It is estimated that the Middle East holds a majority of the market within the Middle Eastern and African region. 

Key Players

Some of the key players in this market are Actavis (U.S.), Chugai Pharmaceutical (Japan), Ferring International Center S.A.(Switzerland), Synergy Pharmaceuticals (U.S.), Pfizer Inc (U.S.), GlaxoSmithKline (U.K.), Sanofi (France), Bayer (Germany), Salix Pharmaceuticals Ltd (U.S.), Sucampo Pharmaceuticals Inc (U.S.), Ironwood Pharmaceuticals (U.S.), Progenics Pharmaceuticals (U.S.), F. Hoffmann-La Roche AG (Switzerland), Boehringer Ingelheim GmbH (Germany), Daewoong Co. Ltd.(South Korea), Synergy Pharmaceuticals, Inc. (U.S.), and others.

Access Report Details @ https://www.marketresearchfuture.com/reports/chronic-idiopathic-constipation-market-5931

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 628 258 0071

Email: sales@marketresearchfuture.com


Location: New York, NY, USA

Comments

Post a Comment

Popular posts from this blog

Chromatography Software Market Size, Revenue Analysis, Industry Outlook, Forecast Till 2030

Image
According to MRFR analysis, the global  Chromatography Software Market  is expected to register a CAGR of ~8.1% from 2022 to 2030 and hold a value of USD 15,330 million by 2030. Chromatography software is the gadget that allows chromatography-based analysis. This software system organizes and manages data from chromatography instruments, records and processes it, and generates chromatograms and reports. Data processing, instrument control, and database management are automated using this chromatography data software. Chromatography informatics solutions are available in various formats, from integrated to automated independent software platforms. These tools are employed in multiple sectors, including materials science, drug development, and forensics. The growing demand for chromatography applications in different fields, surge in the utilization of chromatography techniques in R&D activities across various industries such as the pharmaceutical industry and increasing tec...
Read more

Herbal Medicine Market Size, Opportunities, Trends, Growth Factors, Revenue Analysis Till 2030

Image
The  Herbal Medicine market  is estimated to be valued at USD 1,29,689.3 million by 2023 and expected to grow at a CAGR of 5.88% during the forecast period. The growing prevalence of cancer and infectious diseases across the globe, improving healthcare infrastructure, and skilled professionals are driving the growth of hospital and retail pharmacies in the herbal medicine market. The hospital & retail pharmacies segment accounted for the largest market share of 55.82% in 2017. Various government organizations such as the National Institutes of Health (NIH) have increased the spending on the research of medicinal applications of various plants for the treatment of various chronic diseases such as cancer, arthritis, and many more. According to the National Centre for Biotechnology Information, the National Institutes of Health (NIH) spent USD 111,275,219 on all cannabinoid research in 2015. The increasing acceptance of herbal medicines globally and raising funds for their de...
Read more

Hematology Diagnostics Market Trends, Key Players, DROT, Analysis & Forecast Till 2027

Image
  Hematology Diagnostics Market  The renewed emphasis on health and wellness has prompted an increased focus on blood-related disorders as well. Market reports connected with the healthcare industry have been presented by Market Research Future which makes reports on other industry verticals that aims to analyze the current market scenarios better. The market is set to profit from the positive CAGR in the market during the forecast period. The increased prevalence of blood-related disorders is motivating the expansion of the  hematology diagnostics market . Moreover, the development in the detection and diagnostic methods has improved the growth of the market for hematology diagnostics. The increased involvement of genetic diseases in blood-related ailments is projected to fuel the development of the hematology diagnostic market in the coming years. Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/6262 Segmental Analysis: The segment...
Read more